MARK2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.656800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.172000E-01
Normal-vs-Stage2
4.989800E-01
Normal-vs-Stage3
3.980400E-01
Normal-vs-Stage4
5.708200E-01
Stage1-vs-Stage2
9.046400E-01
Stage1-vs-Stage3
1.117960E-01
Stage1-vs-Stage4
9.066600E-01
Stage2-vs-Stage3
4.827900E-02
Stage2-vs-Stage4
9.749000E-01
Stage3-vs-Stage4
2.342000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.204600E-01
Normal-vs-AfricanAmerican
2.533600E-01
Normal-vs-Asian
3.669400E-01
Caucasian-vs-AfricanAmerican
2.294800E-01
Caucasian-vs-Asian
2.777000E-01
AfricanAmerican-vs-Asian
7.766800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.963800E-01
Normal-vs-Female
6.750400E-01
Male-vs-Female
2.527200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.890800E-01
Normal-vs-Age(41-60Yrs)
2.755400E-01
Normal-vs-Age(61-80Yrs)
7.276000E-01
Normal-vs-Age(81-100Yrs)
8.214600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.752000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.888600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.913400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.711820E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.124200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.912000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.447600E-01
Normal-vs-Daily Drinker
5.826600E-01
Normal-vs-Weekly Drinker
9.354200E-01
Normal-vs-Occasional Drinker
1.399240E-01
Normal-vs-Social Drinker
4.005400E-01
Non Drinker-vs-Daily Drinker
7.359800E-01
Non Drinker-vs-Weekly Drinker
4.646200E-01
Non Drinker-vs-Occasional Drinker
1.088420E-01
Non Drinker-vs-Social Drinker
8.783400E-01
Daily Drinker-vs-Weekly Drinker
3.590600E-01
Daily Drinker-vs-Occasional Drinker
2.739000E-01
Daily Drinker-vs-Social Drinker
8.417000E-01
Weekly Drinker-vs-Occasional Drinker
2.715900E-02
Weekly Drinker-vs-Social Drinker
3.319000E-01
Occasional Drinker-vs-Social Drinker
1.107950E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.891600E-02
Normal-vs-Grade 2
1.231670E-02
Normal-vs-Grade 3
7.360700E-04
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.200100E-02
Grade 1-vs-Grade 3
6.028300E-04
Grade 1-vs-Grade 4
5.891600E-02
Grade 2-vs-Grade 3
3.013500E-02
Grade 2-vs-Grade 4
1.231670E-02
Grade 3-vs-Grade 4
7.360700E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.457200E-01
Normal-vs-NonDiabetic
5.264600E-01
Diabetic-vs-NonDiabetic
3.849200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.567800E-02
Normal-vs-NoPancreatitis
6.474000E-01
Pancreatitis-vs-NoPancreatitis
9.599300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.176400E-01
Normal-vs-N1
5.718000E-01
N0-vs-N1
9.953400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.396000E-02
Normal-vs-TP53-NonMutant
6.028400E-01
TP53-Mutant-vs-TP53-NonMutant
6.426900E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
